These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 26155959)

  • 1. iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines.
    Moise L; Gutierrez A; Kibria F; Martin R; Tassone R; Liu R; Terry F; Martin B; De Groot AS
    Hum Vaccin Immunother; 2015; 11(9):2312-21. PubMed ID: 26155959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools.
    De Groot AS; Moise L; Terry F; Gutierrez AH; Hindocha P; Richard G; Hoft DF; Ross TM; Noe AR; Takahashi Y; Kotraiah V; Silk SE; Nielsen CM; Minassian AM; Ashfield R; Ardito M; Draper SJ; Martin WD
    Front Immunol; 2020; 11():442. PubMed ID: 32318055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Immunoinformatics Tools for Swine: Designing Epitope-Driven Vaccines, Predicting Vaccine Efficacy, and Making Vaccines on Demand.
    Moise L; Gutiérrez AH; Khan S; Tan S; Ardito M; Martin WD; De Groot AS
    Front Immunol; 2020; 11():563362. PubMed ID: 33123135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoinformatics:
    Bahrami AA; Payandeh Z; Khalili S; Zakeri A; Bandehpour M
    Int Rev Immunol; 2019; 38(6):307-322. PubMed ID: 31478759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational tools for epitope vaccine design and evaluation.
    He L; Zhu J
    Curr Opin Virol; 2015 Apr; 11():103-12. PubMed ID: 25837467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current progress of immunoinformatics approach harnessed for cellular- and antibody-dependent vaccine design.
    Kazi A; Chuah C; Majeed ABA; Leow CH; Lim BH; Leow CY
    Pathog Glob Health; 2018 May; 112(3):123-131. PubMed ID: 29528265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant and epitope-based vaccines on the road to the market and implications for vaccine design and production.
    Oyarzún P; Kobe B
    Hum Vaccin Immunother; 2016 Mar; 12(3):763-7. PubMed ID: 26430814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and retrospective validation of T-cell epitopes in the hepatitis C virus genotype 4 proteome: an accelerated approach toward epitope-driven vaccine development.
    Abdel-Hady KM; Gutierrez AH; Terry F; Desrosiers J; De Groot AS; Azzazy HM
    Hum Vaccin Immunother; 2014; 10(8):2366-77. PubMed ID: 25424944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope-driven DNA vaccine design employing immunoinformatics against B-cell lymphoma: a biotech's challenge.
    Iurescia S; Fioretti D; Fazio VM; Rinaldi M
    Biotechnol Adv; 2012; 30(1):372-83. PubMed ID: 21745560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse Vaccinology: The Pathway from Genomes and Epitope Predictions to Tailored Recombinant Vaccines.
    Michalik M; Djahanshiri B; Leo JC; Linke D
    Methods Mol Biol; 2016; 1403():87-106. PubMed ID: 27076126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational vaccinology and epitope vaccine design by immunoinformatics.
    Khalili S; Jahangiri A; Borna H; Ahmadi Zanoos K; Amani J
    Acta Microbiol Immunol Hung; 2014 Sep; 61(3):285-307. PubMed ID: 25261943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current methods of epitope identification for cancer vaccine design.
    Cherryholmes GA; Stanton SE; Disis ML
    Vaccine; 2015 Dec; 33(51):7408-7414. PubMed ID: 26238725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From immunome to vaccine: epitope mapping and vaccine design tools.
    De Groot AS; Martin W
    Novartis Found Symp; 2003; 254():57-72; discussion 72-6, 98-101, 250-2. PubMed ID: 14712932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope engineering and molecular metrics of immunogenicity: a computational approach to VLP-based vaccine design.
    Joshi H; Lewis K; Singharoy A; Ortoleva PJ
    Vaccine; 2013 Oct; 31(42):4841-7. PubMed ID: 23933338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens.
    Liljeroos L; Malito E; Ferlenghi I; Bottomley MJ
    J Immunol Res; 2015; 2015():156241. PubMed ID: 26526043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV vaccine development by computer assisted design: the GAIA vaccine.
    De Groot AS; Marcon L; Bishop EA; Rivera D; Kutzler M; Weiner DB; Martin W
    Vaccine; 2005 Mar; 23(17-18):2136-48. PubMed ID: 15755584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics tools for identifying class I-restricted epitopes.
    Martin W; Sbai H; De Groot AS
    Methods; 2003 Mar; 29(3):289-98. PubMed ID: 12725794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The two-faced T cell epitope: examining the host-microbe interface with JanusMatrix.
    Moise L; Gutierrez AH; Bailey-Kellogg C; Terry F; Leng Q; Abdel Hady KM; VerBerkmoes NC; Sztein MB; Losikoff PT; Martin WD; Rothman AL; De Groot AS
    Hum Vaccin Immunother; 2013 Jul; 9(7):1577-86. PubMed ID: 23584251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of epitope-based peptide vaccine candidates against enterotoxigenic Escherichia coli: a comparative genomics and immunoinformatics approach.
    Mehla K; Ramana J
    Mol Biosyst; 2016 Mar; 12(3):890-901. PubMed ID: 26766131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICoVax 2013: the 3rd ISV Pre-conference Computational Vaccinology Workshop.
    De Groot AS; De Groot P; He Y
    BMC Bioinformatics; 2014; 15 Suppl 4(Suppl 4):I1. PubMed ID: 25104130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.